Immix Biopharma Stock Drops Significantly On News of Chief Medical Officer Arrest - IMMX Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims

Kehoe Law Firm, P.C. said it is investigating potential securities fraud claims on behalf of investors in Immix Biopharma (NASDAQ: IMMX). The article provides no allegations or financial impact details, but the announcement introduces downside headline risk for the stock as litigation exposure is possible.